Curanex Pharmaceuticals Inc Common Stock (CURX) is a publicly traded the market company. As of October 19, 2026, CURX trades at $4.92 with a market cap of $7.25M and a P/E ratio of -30.85. CURX moved +0.00% today. Year to date, CURX is -25.59%; over the trailing twelve months it is -64.61%. Its 52-week range spans $3.58 to $183.59. Rallies surfaces CURX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for CURX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $4.92 |
| Market Cap | $7.25M |
| P/E Ratio | -30.85 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $183.59 |
| 52-Week Low | $3.58 |
| Volume | 6.51K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-4.23M |
| Gross Margin | 0.00% |
CURX analyst coverage data. Average price target: $0.00.